CircRASSF2 acts as a prognostic factor and promotes breast cancer progression by modulating miR-1205/HOXA1 axis

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Wörmann B. Breast cancer: basics, screening, diagnostics and treatment. Med Monatsschr Pharm. 2017;40(2):55–64.
   PubMedGoogle Scholar
• Patop IL, Wüst S, Kadener S. Past, present, and future of circRNAs. Embo J. 2019;38(16):25.
   Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):017–0663.
   PubMedGoogle Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338.
   PubMed Web of Science ®Google Scholar
• Wang X, Fang L. Advances in circular RNAs and their roles in breast Cancer. J Exp Clin Cancer Res. 2018;37(1):018–0870.
   PubMedGoogle Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388.
   PubMed Web of Science ®Google Scholar
• Wu G, Zhou W, Lin X, et al. circRASSF2 acts as ceRNA and promotes papillary thyroid carcinoma progression through miR-1178/TLR4 signaling pathway. Mol Ther Nucleic Acids. 2020;19:1153–1163. Epub 2020/ 02/16.
   PubMedGoogle Scholar
• Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–1207.
   PubMed Web of Science ®Google Scholar
• Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 2015;5(10):1122–1143.
   PubMed Web of Science ®Google Scholar
• Liu H, Xue L, Song C, et al. Overexpression of circular RNA circ_001569 indicates poor prognosis in hepatocellular carcinoma and promotes cell growth and metastasis by sponging miR-411-5p and miR-432-5p. Biochem Biophys Res Commun. 2018;503(4):2659–2665.
   PubMed Web of Science ®Google Scholar
• Li G, Huang M, Cai Y, et al. Circ-U2AF1 promotes human glioma via derepressing neuro-oncological ventral antigen 2 by sponging hsa-miR-7-5p. J Cell Physiol. 2019;234(6):9144–9155.
   PubMed Web of Science ®Google Scholar
• Wang H, Xiao Y, Wu L, et al. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-000911/miR-449a pathway in breast carcinogenesis. Int J Oncol. 2018;52(3):743–754.
   PubMed Web of Science ®Google Scholar
• Wang L, Long H, Zheng Q, et al. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression. Mol Cancer. 2019;18(1):019–1046.
   PubMedGoogle Scholar
• Xie F, Li Y, Wang M, et al. Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis. Mol Cancer. 2018;17(1):018–0892.
   PubMedGoogle Scholar
• Wu Z, Shi W, Jiang C. Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis. Biochem Biophys Res Commun. 2018;502(4):465–471.
   PubMed Web of Science ®Google Scholar
• Luan Y, Li X, Zhao R, et al. Circulating lncRNA UCA1 promotes malignancy of colorectal cancer via the miR-143/MYO6 axis. Mol Ther Nucleic Acids. 2020;19:790–803.
   PubMedGoogle Scholar
• Liu J, Lu X. HOXA1 upregulation is associated with poor prognosis and tumor progression in breast cancer. Exp Ther Med. 2019;17(3):1896–1902.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li XJ, He RQ, et al. Upregulation of HOXA1 promotes tumorigenesis and development of nonsmall cell lung cancer: a comprehensive investigation based on reverse transcription-quantitative polymerase chain reaction and bioinformatics analysis. Int J Oncol. 2018;53(1):73–86.
   PubMed Web of Science ®Google Scholar
• De Kumar B, Parker HJ, Paulson A, et al. Hoxa1 targets signaling pathways during neural differentiation of ES cells and mouse embryogenesis. Dev Biol. 2017;432(1):151–164.
   PubMed Web of Science ®Google Scholar
• Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer. 2010;10(5):361–371.
   PubMed Web of Science ®Google Scholar
• Santner SJ, Dawson PJ, Tait L, et al. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat. 2001;65(2):101–110.
   PubMed Web of Science ®Google Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94. Epub 2017/ 05/26.
   PubMed Web of Science ®Google Scholar
• Sang Y, Chen B, Song X, et al. circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer. Mol Ther. 2019;27(9):1638–1652. Epub 2019/ 06/04.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang Q, Zhou S, et al. Circular RNA expression in exosomes derived from breast cancer cells and patients. Epigenomics. 2019;11(4):411–421.
   PubMed Web of Science ®Google Scholar
• Okugawa Y, Toiyama Y, Hur K, et al. Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients. J Cachexia Sarcopenia Muscle. 2019;10(3):536–548. Epub 2019/ 05/16.
   PubMed Web of Science ®Google Scholar
• Dong W, Bi J, Liu H, et al. Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axis. Mol Cancer. 2019;18(1):95. Epub 2019/ 05/19.
   PubMedGoogle Scholar
• Rong D, Lu C, Zhang B, et al. CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p. Mol Cancer. 2019;18(1):25. Epub 2019/ 02/20.
   PubMed Web of Science ®Google Scholar
• Yin WB, Yan MG, Fang X, et al. Circulating circular RNA hsa_circ_0001785 acts as a diagnostic biomarker for breast cancer detection. Clin Chim Acta. 2018;487:363–368. Epub 2017/ 10/19.
   PubMed Web of Science ®Google Scholar
• Tian L, Cao J, Jiao H, et al. CircRASSF2 promotes laryngeal squamous cell carcinoma progression by regulating the miR-302b-3p/IGF-1R axis. Clin sci. 2019;133(9):1053–1066. Epub 2019/ 04/18.
   PubMed Web of Science ®Google Scholar
• Park SY, Jeong MS, Han CW, et al. Structural and functional insight into proliferating cell nuclear antigen. J Microbiol Biotechnol. 2016;26(4):637–647. Epub 2015/ 12/25.
   PubMed Web of Science ®Google Scholar
• Cardano M, Tribioli C, Prosperi E. Targeting proliferating cell nuclear antigen (PCNA) as an effective strategy to inhibit tumor cell proliferation. Curr Cancer Drug Targets. 2020;20(4):240–252. Epub 2020/ 01/18.
   PubMed Web of Science ®Google Scholar
• Fan TJ, Han LH, Cong RS, et al. Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai). 2005;37(11):719–727. Epub 2005/ 11/05.
   PubMed Web of Science ®Google Scholar
• Choudhary GS, Al-Harbi S, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol. 2015;1219:1–9. Epub 2014/ 10/14.
   PubMedGoogle Scholar
• Drel VR, Shymans’kyĭ IO, Sybirna NO, et al. Role of PARP and protein poly-ADP-ribosylation process in regulation of cell functions. Ukrains’kyi biokhimichnyi zhurnal (1999). 2011;83(6):5–34. Epub 2012/ 03/01.
   PubMedGoogle Scholar
• Aredia F, Scovassi AI. Poly(ADP-ribose): a signaling molecule in different paradigms of cell death. Biochem Pharmacol. 2014;92(1):157–163. Epub 2014/ 07/01.
   PubMed Web of Science ®Google Scholar
• Jabłońska-Trypuć A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016;31(sup1):177–183. Epub 2016/ 03/31.
   PubMed Web of Science ®Google Scholar
• Pietruszewska W, Bojanowska-Poźniak K, Kobos J. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study. Otolaryngol Pol. 2016;70(3):32–43. Epub 2016/ 07/09.
   PubMedGoogle Scholar
• Nishio K, Motozawa K, Omagari D, et al. Comparison of MMP2 and MMP9 expression levels between primary and metastatic regions of oral squamous cell carcinoma. J Oral Sci. 2016;58(1):59–65. Epub 2016/ 03/30.
   PubMed Web of Science ®Google Scholar
• Winer A, Adams S, Mignatti P. Matrix metalloproteinase inhibitors in cancer therapy: turning past failures into future successes. Mol Cancer Ther. 2018;17(6):1147–1155. Epub 2018/ 05/08.
   PubMed Web of Science ®Google Scholar
• Yan H, Chen X, Li Y, et al. MiR-1205 functions as a tumor suppressor by disconnecting the synergy between KRAS and MDM4/E2F1 in non-small cell lung cancer. Am J Cancer Res. 2019;9(2):312–329.
   PubMed Web of Science ®Google Scholar
• Li P, Lin XJ, Yang Y, et al. Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma. Cell Death Dis. 2019;10(12):019–2154.
   PubMedGoogle Scholar
• Kraft S, Moore JB, Muzikansky A, et al. Differential UBE2C and HOXA1 expression in melanocytic nevi and melanoma. J Cutan Pathol. 2017;44(10):843–850.
   PubMed Web of Science ®Google Scholar
• Li X, Pang L, Yang Z, et al. LncRNA HOTAIRM1/HOXA1 axis promotes cell proliferation, migration and invasion in endometrial cancer. Onco Targets Ther. 2019;12:10997–11015.
   PubMed Web of Science ®Google Scholar
• Chariot A, Castronovo V. Detection of HOXA1 expression in human breast cancer. Biochem Biophys Res Commun. 1996;222(2):292–297.
   PubMed Web of Science ®Google Scholar
• Makiyama K, Hamada J, Takada M, et al. Aberrant expression of HOX genes in human invasive breast carcinoma. Oncol Rep. 2005;13(4):673–679.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhu T, Chen Y, et al. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J Biol Chem. 2003;278(9):7580–7590.
   PubMed Web of Science ®Google Scholar